{"title":"发起人、临床研究者和机构审查委员会之间的相互关系。","authors":"T J Kirsch","doi":"10.1177/009286158702100203","DOIUrl":null,"url":null,"abstract":"<p><p>The responsibilities of sponsors, clinical investigators, and institutional review boards (IRBs) in the conduct of clinical research are summarized and some of the problems which each of these parties has experienced in the conduct of clinical research are described. The paper concludes with specific recommendations to secure appropriate relationships among sponsors, clinical investigators, and IRBs.</p>","PeriodicalId":51023,"journal":{"name":"Drug Information Journal","volume":"21 2","pages":"127-31"},"PeriodicalIF":0.0000,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/009286158702100203","citationCount":"2","resultStr":"{\"title\":\"The interrelationship of sponsors, clinical investigators, and institutional review boards.\",\"authors\":\"T J Kirsch\",\"doi\":\"10.1177/009286158702100203\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The responsibilities of sponsors, clinical investigators, and institutional review boards (IRBs) in the conduct of clinical research are summarized and some of the problems which each of these parties has experienced in the conduct of clinical research are described. The paper concludes with specific recommendations to secure appropriate relationships among sponsors, clinical investigators, and IRBs.</p>\",\"PeriodicalId\":51023,\"journal\":{\"name\":\"Drug Information Journal\",\"volume\":\"21 2\",\"pages\":\"127-31\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1987-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/009286158702100203\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Information Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/009286158702100203\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Information Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/009286158702100203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The interrelationship of sponsors, clinical investigators, and institutional review boards.
The responsibilities of sponsors, clinical investigators, and institutional review boards (IRBs) in the conduct of clinical research are summarized and some of the problems which each of these parties has experienced in the conduct of clinical research are described. The paper concludes with specific recommendations to secure appropriate relationships among sponsors, clinical investigators, and IRBs.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
